15
Participants
Start Date
July 1, 2025
Primary Completion Date
June 30, 2026
Study Completion Date
December 31, 2026
Heart rate-based AI software for detecting thyrotoxicosis
A software-based investigational medical device that uses artificial intelligence to detect the thyrotoxic state in patients with hyperthyroidism. The device analyzes resting heart rate data collected from wearable devices along with thyroid function test results (free T4 and TSH). The device is not FDA-approved and will be used solely for observational performance evaluation without influencing clinical care.
THYROSCOPE INC.
INDUSTRY